NASDAQ:AUPH (Aurinia Pharmaceuticals Inc.)

About AUPH

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.
  • Should you invest $1,000 in Aurinia Pharmaceuticals Inc. right now?

    Before you buy stock in Aurinia Pharmaceuticals Inc., consider this:

    The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aurinia Pharmaceuticals Inc. wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

    Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

    Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

    See the Top Stocks * Returns as of 2/20/25

  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Latest News

    Coronavirus

    3 TSX Stocks Bay Street Expects Could Double or Triple in 1 Year!

    There are lots of TSX stocks out there that continue to be a deal, but these three offer the best…

    Read more »

    Investing

    Value Investors: 1 Pharma Growth Stock With Huge Potential

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) has an extensive granted patent portfolio which makes the company's stock very valuable.

    Read more »

    Stocks for Beginners

    3 Top Canadian Pharma Stocks for Ambitious Investors

    Pharma stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are coming into their own, offering growth investors a lot of upside potential.

    Read more »

    Top TSX Stocks

    3 BioPharm Stocks Yielding 100% Yearly Returns

    Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME), among other Canadian biopharmaceutical companies, has been hit with shorter supplies and rising demand.

    Read more »

    Investing

    3 Stocks That Could Benefit From Canada’s Population Boom

    Stocks like Equitable Group Inc. (TSX:EQB) should benefit from long-term population growth in Canada.

    Read more »

    hospital, aged care facility
    Investing

    Which Canadian Healthcare Stocks Could Make You Rich?

    Sienna Senior Living Inc. (TSX:SIA) and two other Canadian healthcare stocks are performing very differently on the TSX. Are they…

    Read more »

    The Motley Fool
    Investing

    This Unloved Drug Stock Could Have Massive Upside

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) is over-priced, but should that stop you owning one of the most stable high-growth stocks on…

    Read more »

    Investing

    3 High-Performing Stocks to Buy on the Dip

    Air Canada (TSX:AC)(TSX:AC.B) and these two other stocks have had strong performances this year, although they have been on the decline…

    Read more »

    Investing

    TSX Reaches 16,000: These Are 5 of the Highest-Performing Stocks This Year

    These five stocks, including Ballard Power Systems Inc. (TSX:BLDP)(NASDAQ:BLDP), have outperformed.

    Read more »

    Dividend Stocks

    3 Stocks That Have Soared Higher Than Shopify Inc. This Year!

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) and these two other stocks have seen their share prices more than double in 2017.

    Read more »